Insider Trading
| UTMD Stock | USD 61.22 0.09 0.15% |
About 62% of Utah Medical's investor base is looking to short. The analysis of overall sentiment of trading Utah Medical Products stock suggests that many investors are alarmed at this time. The current market sentiment, together with Utah Medical's historical and current headlines, can help investors time the market. In addition, many technical investors use Utah Medical Products stock news signals to limit their universe of possible portfolio assets.
Utah |
Filed transaction by Utah Medical Products Director. Insider Public Trading
Read at macroaxis.com
Utah Medical Fundamental Analysis
We analyze Utah Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Utah Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Utah Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Outstanding
Shares Outstanding Comparative Analysis
Utah Medical is currently under evaluation in shares outstanding category among its peers. Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Utah Medical Products Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Utah Medical stock to make a market-neutral strategy. Peer analysis of Utah Medical could also be used in its relative valuation, which is a method of valuing Utah Medical by comparing valuation metrics with similar companies.
Peers
Utah Medical Related Equities
| POCI | Precision Optics, | 2.40 | ||||
| MMSI | Merit Medical | 1.67 | ||||
| ATR | AptarGroup | 0.65 | ||||
| LMAT | LeMaitre Vascular | 0.23 | ||||
| AKYA | Akoya Biosciences | 0.33 | ||||
| ANGO | AngioDynamics | 0.40 | ||||
| KRMD | Repro Med | 0.70 | ||||
| PDEX | Pro Dex | 0.72 | ||||
| ICUI | ICU Medical | 1.42 | ||||
| MLSS | Milestone Scientific | 1.55 | ||||
| INFU | InfuSystems Holdings | 1.93 | ||||
| ATRC | AtriCure | 4.25 |
Complementary Tools for Utah Stock analysis
When running Utah Medical's price analysis, check to measure Utah Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Utah Medical is operating at the current time. Most of Utah Medical's value examination focuses on studying past and present price action to predict the probability of Utah Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Utah Medical's price. Additionally, you may evaluate how the addition of Utah Medical to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |